BlueWillow Biologics' Private Equity - IV Round

BlueWillow Biologics raised a round of funding on November 28, 2012. Investors include Perseus.

BlueWillow Biologics develops and commercializes intranasal vaccines using its patented NanoVax┬« technology platform. The technology employs an oil-in-water nanoemulsion adjuvant that is effective wh…

Articles about BlueWillow Biologics' Private Equity - IV Round: